SCHOTT Pharma AG & Co. KGaA (SHTPY)
4.37
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
SCHOTT Pharma Gross Profit Margin (Quarterly) : 30.66% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.66% |
| March 31, 2026 | 30.30% |
| December 31, 2025 | 33.20% |
| September 30, 2025 | 30.73% |
| June 30, 2025 | 37.45% |
| March 31, 2025 | 33.12% |
| December 31, 2024 | 33.48% |
| Date | Value |
|---|---|
| September 30, 2024 | 30.67% |
| June 30, 2024 | 34.34% |
| March 31, 2024 | 33.76% |
| December 31, 2023 | 36.06% |
| September 30, 2023 | 32.51% |
| December 31, 2022 | 36.06% |
| September 30, 2022 | 30.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 37.83% |
| Drägerwerk AG & Co. KGaA | 46.64% |
| Sartorius AG | 47.50% |
| Reflect Scientific, Inc. | 42.89% |
| Ottobock SE & Co. KGaA | 52.83% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.83% |
| Return on Assets | 8.48% |
| Return on Invested Capital | 14.56% |
| Profit Margin (Quarterly) | 13.83% |
| Operating Margin (Quarterly) | 15.88% |
| Return on Net Operating Assets | 10.51% |